Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks mixed as ex-divs drag on FTSE

Thu, 16th May 2024 16:53

(Sharecast News) - London stocks ended mixed on Thursday, following a flurry of corporate news and a focus on US unemployment figures.

The FTSE 100 dipped 0.08% to close at 8,438.65, impacted by ex-dividend shares, while the FTSE 250 saw a modest rise of 0.23%, closing at 20,822.84.

In currency markets, sterling was last down 0.06% against the dollar, trading at $1.2678, while it inched up 0.03% on the euro to change hands at €1.1659.

"The FTSE 100 finds itself unchanged on the day as the close looms, as gains for HSBC are countered by losses for Shell, while further down the weightings BT's 15% gain, adding four points to the index is neatly countered by Sage's sharp drop," said IG chief market analyst Chris Beauchamp.

"Overall the index continues to consolidate around its previous highs, and even yesterday's US CPI data had only a moderately-supportive effect."

Beauchamp noted that oil had been volatile so far this month, although it looked like prices were forming a low.

"The calming of tensions in the Middle East removed one driver of higher prices, but a weakening dollar and hopes of stronger oil demand in the second half have helped buyers to muster up the strength to support the price around current levels."

Jobless claims fall less than expected in the US

In a quiet day for UK and European economic data, US jobless claims and manufacturing activity took centre stage during the afternoon.

According to the US Department of Labor, initial unemployment claims fell by 10,000 to 222,000 for the week ended 11 May, surpassing economists' expectations of 220,000.

However, the four-week moving average of claims rose by 2,500 to 217,750.

Continuing claims, which cover the week ending 4 May, increased by 13,000 to 1.794 million.

Meanwhile, factory activity in the US mid-Atlantic region slowed more than anticipated in May.

The Federal Reserve Bank of Philadelphia's manufacturing index dropped from 15.5 in April to 4.5, below the expected decline to 8.

A significant decrease in new orders, from 12.2 to -7.9, contributed to this slowdown.

The prices paid sub-index also decreased, from 23.0 to 18.7, while the employment sub-index showed a slight improvement, rising from -10.7 to -7.9.

In Asia, Japan's economy unexpectedly contracted by 2% on an annualised basis in the first quarter, driven by reduced consumer spending, lower corporate investment, and falling exports.

It was a larger contraction than the forecasted 1.2% decline, casting doubt on the Bank of Japan's plans to raise interest rates.

The country's economic challenges were exacerbated by issues at Toyota's subsidiary Daihatsu, which faced a government-ordered production halt due to falsified safety test results, and a devastating earthquake near Tokyo on New Year's Day.

Additionally, revised data for the fourth quarter of last year indicated flat GDP, marking nine months of stagnant growth.

Ex-dividends drag on top-flight index, BT jumps on savings plans

On London's equity markets, BP was down 1.3%, GSK lost 1.9%, Kingfisher was off 2.75%, Shell slipped 1.4%, Tesco slid 1.13%, Bunzl weakened 2.12%, and Essentra closed behind by 1.2%, as they all traded without entitlement to the dividend.

Sage Group slumped 8.81%, despite reporting solid first-half results, after it trimmed its annual revenue guidance.

EasyJet fell 5.57% following the announcement that chief executive officer Johan Lundgren would step down in early 2025, succeeded by current finance chief Kenton Jarvis.

The announcement coincided with a narrower first-half pre-tax loss of £350m, down from £411m a year earlier.

Wizz Air Holdings lost 3.52%, while ConvaTec Group declined 3.08%, even after it maintained top-level guidance for 2024.

The fall was attributed to reduced growth forecasts in its advanced wound care division due to "short-term uncertainty."

On the upside, BT Group surged 16.7%, despite a 31% drop in annual profits, driven by plans to save £3bn annually by the end of the decade.

Watches of Switzerland Group jumped 18.41%, buoyed by a 4% rise in sales in the final quarter of its financial year and a "cautiously optimistic" outlook.

Future saw one of the largest increases, rocketing 19.89% on news of a £45m share buyback, despite reporting a fall in half-year revenues and profits.

Elsewhere, Auction Technology Group added 15.45% and Helios Towers jumped 11.96%, following their own results announcements.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 8,438.65 -0.08%

FTSE 250 (MCX) 20,822.84 0.23%

techMARK (TASX) 4,792.16 0.14%

FTSE 100 - Risers

BT Group (BT.A) 132.60p 17.19%

Burberry Group (BRBY) 1,140.00p 3.45%

Prudential (PRU) 827.40p 2.94%

Rio Tinto (RIO) 5,649.00p 2.30%

Diploma (DPLM) 4,210.00p 2.13%

Phoenix Group Holdings (PHNX) 525.50p 2.04%

Intermediate Capital Group (ICG) 2,284.00p 1.96%

Vodafone Group (VOD) 77.52p 1.87%

Sainsbury (J) (SBRY) 282.20p 1.80%

B&M European Value Retail S.A. (DI) (BME) 544.60p 1.76%

FTSE 100 - Fallers

Sage Group (SGE) 1,084.50p -9.44%

easyJet (EZJ) 497.70p -5.99%

Convatec Group (CTEC) 255.00p -4.06%

International Consolidated Airlines Group SA (CDI) (IAG) 176.95p -2.80%

Kingfisher (KGF) 261.60p -2.75%

Croda International (CRDA) 4,751.00p -2.70%

Pearson (PSON) 958.60p -2.62%

Entain (ENT) 764.20p -2.53%

Hikma Pharmaceuticals (HIK) 1,983.00p -2.22%

Bunzl (BNZL) 3,044.00p -2.12%

FTSE 250 - Risers

Watches of Switzerland Group (WOSG) 405.00p 19.89%

Future (FUTR) 1,030.00p 18.39%

Auction Technology Group (ATG) 564.00p 14.63%

Helios Towers (HTWS) 123.60p 11.96%

TBC Bank Group (TBCG) 2,670.00p 5.53%

Diversified Energy Company (DEC) 1,142.00p 3.72%

OSB Group (OSB) 467.40p 3.64%

WH Smith (SMWH) 1,173.00p 3.53%

Direct Line Insurance Group (DLG) 203.40p 3.46%

Crest Nicholson Holdings (CRST) 225.40p 3.11%

FTSE 250 - Fallers

Spectris (SXS) 3,148.00p -4.66%

Wizz Air Holdings (WIZZ) 2,116.00p -4.60%

Tritax Eurobox (GBP) (EBOX) 59.60p -3.87%

Octopus Renewables Infrastructure Trust (ORIT) 72.50p -3.72%

Jupiter Fund Management (JUP) 83.50p -3.48%

TUI AG Reg Shs (DI) (TUI) 573.00p -3.05%

Grainger (GRI) 264.00p -2.94%

Balfour Beatty (BBY) 372.20p -2.87%

SDCL Energy Efficiency Income Trust (SEIT) 65.00p -2.84%

Indivior (INDV) 1,352.00p -2.38%

More News
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.